David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$327M |
| 2 |
Netflix
NFLX
|
+$275M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$219M |
| 4 |
Citigroup
C
|
+$211M |
| 5 |
Merck
MRK
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DELL
DELL INC
DELL
|
+$558M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
+$259M |
| 3 |
Meta Platforms (Facebook)
META
|
+$252M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$252M |
| 5 |
IBM
IBM
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.49% |
| 2 | Technology | 7.17% |
| 3 | Consumer Discretionary | 7.02% |
| 4 | Healthcare | 6.66% |
| 5 | Communication Services | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
PUT
Danaher
DHR
$151B
| $19.1M | 0.03% |
368,090
+176,755
| +92% | +$8.69M |
|
702
Lowe's Companies
LOW
$122B
| $19M | 0.03% |
383,838
-692,789
| -64% | -$33.7M |
|
703
FMC
FMC
$1.41B
| $19M | 0.03% |
290,343
+253,050
| +679% | +$16.1M |
|
704
BP
BP
$113B
| $19M | 0.03% |
477,430
+386,655
| +426% | +$14.4M |
|
|
Y
705
DELISTED
Alleghany Corp
Y
| $18.9M | 0.03% |
47,215
+31,854
| +207% | +$12.7M |
|
|
GTLS
706
DELISTED
Chart Industries
GTLS
| $18.8M | 0.03% |
197,080
+181,239
| +1,144% | +$19.1M |
|
707
Regal Rexnord
RRX
$10.8B
| $18.8M | 0.03% |
255,639
+204,790
| +403% | +$14.9M |
|
708
CALL
Cisco
CSCO
$434B
| $18.8M | 0.03% |
836,200
+531,300
| +174% | +$11.8M |
|
709
Intuitive Surgical
ISRG
$132B
| $18.8M | 0.03% |
439,776
+278,586
| +173% | +$11.7M |
|
710
Vale
VALE
$64B
| $18.8M | 0.03% |
1,229,625
+573,001
| +87% | +$8.91M |
|
|
EVRI
711
DELISTED
Everi Holdings
EVRI
| $18.7M | 0.03% |
1,873,161
+144,902
| +8% | +$1.27M |
|
712
CALL
DuPont de Nemours
DD
$18.5B
| $18.7M | 0.03% |
165,929
-273,613
| -62% | -$28M |
|
|
SNDK
713
DELISTED
SANDISK CORP
SNDK
| $18.6M | 0.03% |
264,070
+38,348
| +17% | +$2.58M |
|
714
Teradyne
TER
$57B
| $18.6M | 0.03% |
1,056,777
+397,189
| +60% | +$6.71M |
|
715
PUT
Nike
NKE
$60.5B
| $18.6M | 0.03% |
472,800
+352,800
| +294% | +$13.5M |
|
716
BioCryst Pharmaceuticals
BCRX
$2.47B
| $18.5M | 0.03% |
2,440,177
+1,617,669
| +197% | +$10.2M |
|
717
FedEx
FDX
$79.1B
| $18.5M | 0.03% |
128,825
+60,921
| +90% | +$8.07M |
|
718
PUT
Illinois Tool Works
ITW
$80.9B
| $18.5M | 0.03% |
220,100
+111,300
| +102% | +$8.78M |
|
|
IPXL
719
DELISTED
Impax Laboratories, Inc.
IPXL
| $18.5M | 0.03% |
735,799
+168,495
| +30% | +$3.76M |
|
|
PAY
720
DELISTED
Verifone Systems Inc
PAY
| $18.5M | 0.03% |
689,627
-983,650
| -59% | -$23.5M |
|
721
PUT
Texas Instruments
TXN
$236B
| $18.5M | 0.03% |
420,900
-10,600
| -2% | -$444K |
|
722
CALL
AbbVie
ABBV
$467B
| $18.4M | 0.03% |
348,600
+29,800
| +9% | +$1.46M |
|
723
PUT
Packaging Corp of America
PKG
$22.2B
| $18.4M | 0.03% |
290,700
+5,100
| +2% | +$310K |
|
|
AMTD
724
PUT
DELISTED
TD Ameritrade Holding Corp
AMTD
| $18.4M | 0.03% |
599,000
| – | – |
|
725
PUT
Markel Group
MKL
$22.5B
| $18.3M | 0.02% |
31,500
+20,000
| +174% | +$10.9M |
|
Similar funds
David Shaw's Q4 2013 Portfolio in Review
As of Q4 2013, David Shaw held 4,972 positions worth $73.3B, up 17% from $62.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
David Shaw deployed $3.59B of net new capital in Q4 2013, opening 721 new positions and adding to 1,786 existing holdings. Its largest new stake was Allegion: 2,233,249 shares worth $98.7M.
By sector, the portfolio is most concentrated in Financials at 7.5% of assets, up from 7% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $252M trimmed.
- David Shaw's largest Q4 2013 buy was Allegion: 2,233,249 shares worth $98.7M.
- David Shaw added most to Bank of America in Q4 2013, an estimated $327M increase.
- David Shaw's biggest Q4 2013 reduction was Meta Platforms (Facebook), cutting an estimated $252M.
- David Shaw fully exited DELL INC in Q4 2013, selling an estimated $558M.
- David Shaw's ten largest holdings make up 13% of its $73.3B portfolio in Q4 2013.
- David Shaw opened 721 new positions and closed 549 in Q4 2013.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $73.3B.
Based on D.E. Shaw & Co's 13F filing for Q4 2013, filed 14 Feb 2014.